Senior Associate Scientist, Routine Assays
Bristol Myers Squibb
Summary
Bristol Myers Squibb is seeking a motivated and detail-oriented (Senior) Associate Scientist to join our Analytical Sciences team. In this role, you will support routine and non-routine analytical testing activities critical to the advancement of our RNA focused drug discovery and development pipeline.
Job description
The ideal candidate possesses hands-on laboratory experience, a strong scientific foundation, and a commitment to data quality and compliance.
Requirements
- Hands-on laboratory experience
- Strong scientific foundation
- Commitment to data quality
- Commitment to compliance
- Detail-oriented
Benefits
- Wellbeing Support
- Retirement Benefits
- Financial Protection Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Flexible Time Off
- Paid Company Holidays
- Paid Sick Leave
- Paid Volunteer Days
- Summer Hours Flexibility
- Leaves of Absence
- Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.